GGrantIndex
← Leaderboards

Jane E Hitti

University Of Washington

$2,443,105
Attributed
$2,443,105
Total exposure
10
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $383.6K · FY200510
$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10

Funding mix

By agency

NIH$2,443,105 · 10

By mechanism

R01$1,442,213 · 1
R21$869,878 · 1
R03$80,640 · 1
M01$50,374 · 5
P01$0 · 2

Top collaborators

No co-investigators on record.

Most similar at University Of Washington

Same institution · by research overlap

Others in their field

Top investigators on “Female

Research focus

FemaleHuman SubjectClinical ResearchWomen'S HealthLactobacillusHiv InfectionsPatient Oriented ResearchInflammationPolymerase Chain ReactionTumor Necrosis Factor AlphaCervical /Vaginal SmearMicroorganism Disease ChemotherapyBiopsyHuman Therapy EvaluationPremature LaborClinical TrialsHuman Immunodeficiency Virus 1Genetic PolymorphismInterviewCaucasian AmericanAfrican AmericanAntiaids AgentHydrogen PeroxideBacteria Infection Mechanism

Grant awards (22)

Effect of Lactobacillus on genital HIV-1 RNA and DNA shedding in women$383,550
R21 · FY2010 · AI · contact PI
Effect of Lactobacillus on genital HIV-1 RNA and DNA shedding in women$117,000
R21 · FY2009 · AI · contact PI
Effect of Lactobacillus on genital HIV-1 RNA and DNA shedding in women$369,328
R21 · FY2008 · AI · contact PI
Mechanisms for Racial Disparity in Preterm Birth$261,954
R01 · FY2006 · HD · contact PI
PACTG P1026S: PK PROPERTIES OF ANTIRETROVIRAL DRUGS DURING PREGNANCY$9,235
M01 · FY2006 · RR · contact PI
M. genitalium: behavioral and reproductive correlates$40,320
R03 · FY2005 · TW
EFAVIRENZ PHARMACOKINETICS DURING AND AFTER PREGNANCY$15,460
M01 · FY2005 · RR
PACTG P1026S: PK PROPERTIES OF ANTIRETROVIRAL DRUGS DURING PREGNANCY$7,730
M01 · FY2005 · RR
VIROLOGIC/IMMUNOLOGIC CHANGES IN HIV-INFECTED WOMEN POSTPARTUM (ACRG5150)$5,156
M01 · FY2005 · RR
Mechanisms for Racial Disparity in Preterm Birth$268,259
R01 · FY2004 · HD
M. genitalium: behavioral and reproductive correlates$40,320
R03 · FY2004 · TW
PK interaction between DMPA, Depo-provera and PI, and NNRTI$6,398
M01 · FY2004 · RR
PROTEASE REGIMENS FOR WOMEN WHO INITIATE HIV-1 THERAPY DURING PREGNANCY$4,265
M01 · FY2004 · RR
PACTG P1026S: PK PROPERTIES OF ANTIRETROVIRAL DRUGS DURING PREGNANCY$1,065
M01 · FY2004 · RR
VIROLOGIC/IMMUNOLOGIC CHANGES IN HIV-INFECTED WOMEN POSTPARTUM (ACRG5150)$1,065
M01 · FY2004 · RR
Mechanisms for Racial Disparity in Preterm Birth$304,000
R01 · FY2003 · HD
Mechanisms for Racial Disparity in Preterm Birth$304,000
R01 · FY2002 · HD
CORE--CLINICAL$0
P01 · FY2002 · HD
CORE--CLINICAL$0
P01 · FY2002 · HD
BACTERIAL VAGINITIS AS A COFACTOR FOR HIV1 SHEDDING$0
P01 · FY2002 · HD
BACTERIAL VAGINITIS AS A COFACTOR FOR HIV1 SHEDDING$0
P01 · FY2002 · HD
Mechanisms for Racial Disparity in Preterm Birth$304,000
R01 · FY2001 · HD